-IndiaToday.in The Central Drugs Standard Control Organisation (CDSCO) has not yet barred the company from operations in India even as many of its medical products made for Indian use have also been found to be of substandard quality, often flagged by authorities. Ever since Maiden Pharmaceuticals has come under the scanner of the World Health Organisation (WHO) after being flagged for the four cough syrups manufactured in India and exported to Gambia...
More »SEARCH RESULT
Cutting corners on medicine -Vidya Krishnan
-The Hindu Consumption of poor quality medicines could be accelerating drug resistance. India has to share some of the blame It is common for patients to stop taking medicines as soon as they start feeling better. Doctors have blamed this particular habit — of not completing the entire dose of antibiotics — to the emergence of drug resistant strains in diseases such as malaria and tuberculosis (TB). However, experts say that under-dosing,...
More »Ramdev's Patanjali products fail quality test, RTI inquiry finds -MS Nawaz and Anupam Trivedi
-Hindustan Times An RTI query revealed that Patanjali’s Divya Amla Juice and Shivlingi Beej failed to meet the quality standards. The lab report said 31.68% of foreign matter was found in Shivlingi Beej and amla juice had less than the prescribed limit of pH value. Nearly 40% of Ayurveda products, including items from Baba Ramdev’s Patanjali, were found to be of substandard quality by Haridwar’s Ayurveda and Unani Office, a Right to...
More »Can doctors judge best quality in medicines? -Jyotsna Singh
-The Hindu Doctors’ objections to prescribing medicines by generic names fly in the face of a recent report on substandard drugs In a surprise move on April 17, Prime Minister Narendra Modi announced that his government will soon make it mandatory for doctors to prescribe medicines by generic names. The decision was to ensure drug prices remain affordable and patients get a wider bouquet of options instead of being forced to...
More »Generic medicines in a digital age -Dinesh S Thakur & Prashant Reddy T
-The Hindu We need a legal mechanism to ensure that all generics are of the same standard as the innovator product The Prime Minister’s recent announcement on making it mandatory for doctors to prescribe only the generic name, and not brand name of a drug, has led to a flutter. If enacted, the move will make it illegal for Indian doctors to write out a prescription for the trademark of the drug,...
More »